Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18547ExperimentalCell transplant therapies
SIG-207 is a Cultured human retinal pigment epithelial cells (ARPE-19) genetically modified with a non-viral vector to express Human alpha-galactosidase A (alpha-Gal A), encapsulated within two-layer modified alginate spheres.
- Code names
- SIG-207
Which companies are running trials of SIG-207, in which indications and phases, and which of those programs are still active?